jessica, Author at Advanced Medical Québec

Developing the Medical Technology Industry in Canada

It was 1949, and cardiologists Drs. Wilfred Bigelow and John Callaghan were researching whether dramatically cooling a dog’s body would enable them to execute open-heart surgery in the basement of Toronto’s Banting Institute. Unfortunately, the dog’s heart spontaneously stopped during the operation.
Dr. Bigelow, desperate to resuscitate the animal, poked the dog’s left ventricle with his hand. The movement, which resembled the rhythm of a regular heartbeat, jolted the heart back from the dead. It also triggered the thought that electrical …

Life Sciences

IntelGenx to Double in Value Next Year

On Thursday, IntelGenx, a drug delivery development company that produces and sells pharmaceutical films such as VersaFilm and transdermal VevaDerm, reported its Q4 full year 2020 financials, reporting fourth-quarter sales of $790,000 with an adjusted EBITDA loss of $754,000.
After IntelGenx Technologies’ recent fourth-quarter report, Douglas Loe, an analyst at Leede Jones Gable, is optimistic about the venture. Loe disclosed a C$1.00 target price in an update to investors, representing a forecast one-year return of 100% at the time of publishing….

Life Sciences

Clarus Securities Pulls Back on StageZero Life Sciences

StageZero, headquartered in Richmond, Virginia, offers cancer and COVID-19 diagnostic tests and is promoting its Aristotle diagnostic tool as a multi-cancer blood screening. The company disclosed a purchase agreement to acquire Health Clinics Ltd (HCL), a telehealth company dealing with systemic inflammation and metabolic disorders.
Following that, StageZero announced that Aristotle would be launched via HCL’s network and the newly developed AVRT clinical project. StageZero is charging $1,500 for the procedure, which includes a wide variety of tests for …

Medical Tourism

Will Canada’s Marijuana Industry Grow?

Justin Trudeau’s liberal administration is now displaying every intention of keeping its pledge to transform Canada’s cannabis environment. Aside from that, much remains uncertain, including the size of the Canadian marijuana market, the number of people it will hire, and the amount of tax revenue the state will receive.
Previously in early 2016, CIBC World Markets reported that legalized marijuana might become a $10 billion a year business, with the federal and state governments collecting $5 billion in tax revenue. The study concluded that, when …

Medical Tourism

Canada Becoming a Popular Medical Tourism Spot

According to a recent study on the global trade in medical tourism, governments worldwide are increasing their efforts to attract affluent travelers for medical care. This involves medical tourism in Canada, where it is viewed as a promising revenue stream for medical facilities.
According to Yanick Labrie, a Fraser Institute researcher, an increasing number of Canadians believe they must travel abroad to receive necessary medical treatment. One of the most often cited reasons for the trend is the long wait period for treatments in Canada. It is a sign of …

Life Sciences

Better Options to Pfizer Stock

COVID-19 has pushed drugmakers like Pfizer to the forefront of the global effort to find a cure for the pandemic, and its stock price has risen in a month or so after the company announced promising testing results for its COVID vaccine. Investors hoping for a large windfall from Pfizer, according to portfolio manager John Zechner, are likely to be disappointed.
According to Zecher, the issue with larger providers such as Pfizer is that due to their scale and production, it is difficult for them to discover products that will help them expand. The vaccine will …